Alan Go to Cost-Benefit Analysis
This is a "connection" page, showing publications Alan Go has written about Cost-Benefit Analysis.
Connection Strength
0.168
-
Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL. Circ Arrhythm Electrophysiol. 2016 06; 9(6).
Score: 0.126
-
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med. 2011 Jan 04; 154(1):1-11.
Score: 0.021
-
Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapy. Circulation. 2010 Oct 12; 122(15):1478-87.
Score: 0.021